FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2598334911> ?p ?o ?g. }

• W2598334911 endingPage "656" @default.
• W2598334911 startingPage "646" @default.
• W2598334911 abstract "The BRAF inhibitor dabrafenib was recently approved for the treatment of certain BRAF V600 mutation-positive tumors, either alone or in combination therapy with the mitogen-activated extracellular signal regulated kinase 1 (MEK1) and MEK2 inhibitor, trametinib. This article presents the dabrafenib transporter-mediated drug-drug interaction (DDI) risk assessment, which is currently an important part of drug development, regulatory submission, and drug registration. Dabrafenib and its major circulating metabolites (hydroxy-, carboxy-, and desmethyl-dabrafenib) were investigated as inhibitors of the clinically relevant transporters P-gp, BCRP, OATP1B1, OATP1B3, OCT2, OAT1, and OAT3. The DDI Guidance risk assessment decision criteria for inhibition of BCRP, OATP1B1 and OAT3 were slightly exceeded and therefore a minor DDI effect resulting from inhibition of these transporters remained possible. Biliary secretion is the major excretion pathway of dabrafenib-related material (71.1% of orally administered radiolabeled dose recovered in feces), whereas urinary excretion was observed as well (22.7% of the dose). In vitro uptake into human hepatocytes of the dabrafenib metabolites, but not of dabrafenib parent compound, was mediated, at least in part, by hepatic uptake transporters. The transporters responsible for uptake of the pharmacologically active hydroxy- and desmethyl dabrafenib could not be identified, whereas carboxy-dabrafenib was a substrate of several OATPs. Dabrafenib, hydroxy-, and desmethyl-dabrafenib were substrates of P-gp and BCRP, whereas carboxy-dabrafenib was not. Although a small increase in exposure to carboxy-dabrafenib upon inhibition of OATPs and an increase in exposure to desmethyl-dabrafenib upon inhibition of P-gp or BCRP cannot be excluded, the clinical significance of such increases is likely to be low." @default.
• W2598334911 created "2017-04-07" @default.
• W2598334911 creator A5006467688 @default.
• W2598334911 creator A5007497847 @default.
• W2598334911 creator A5029942953 @default.
• W2598334911 creator A5050034362 @default.
• W2598334911 creator A5058921891 @default.
• W2598334911 creator A5072835730 @default.
• W2598334911 date "2017-03-20" @default.
• W2598334911 modified "2023-09-26" @default.
• W2598334911 title "Prediction of the Transporter-Mediated Drug-Drug Interaction Potential of Dabrafenib and Its Major Circulating Metabolites" @default.
• W2598334911 cites W1547515123 @default.
• W2598334911 cites W1639816057 @default.
• W2598334911 cites W1903238701 @default.
• W2598334911 cites W1965370740 @default.
• W2598334911 cites W1973810935 @default.
• W2598334911 cites W1975640964 @default.
• W2598334911 cites W1977607846 @default.
• W2598334911 cites W2011826559 @default.
• W2598334911 cites W2012689925 @default.
• W2598334911 cites W2044543470 @default.
• W2598334911 cites W2060612591 @default.
• W2598334911 cites W2067254007 @default.
• W2598334911 cites W2079197876 @default.
• W2598334911 cites W2092383314 @default.
• W2598334911 cites W2094804146 @default.
• W2598334911 cites W2099141502 @default.
• W2598334911 cites W2100105805 @default.
• W2598334911 cites W2106494998 @default.
• W2598334911 cites W2110287784 @default.
• W2598334911 cites W2111483198 @default.
• W2598334911 cites W2118320294 @default.
• W2598334911 cites W2127379750 @default.
• W2598334911 cites W2131259606 @default.
• W2598334911 cites W2140494950 @default.
• W2598334911 cites W2148587422 @default.
• W2598334911 cites W2161213051 @default.
• W2598334911 cites W2163188200 @default.
• W2598334911 cites W2163795546 @default.
• W2598334911 cites W2166262263 @default.
• W2598334911 cites W2216211177 @default.
• W2598334911 doi "https://doi.org/10.1124/dmd.116.073932" @default.
• W2598334911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28320730" @default.
• W2598334911 hasPublicationYear "2017" @default.
• W2598334911 type Work @default.
• W2598334911 sameAs 2598334911 @default.
• W2598334911 citedByCount "10" @default.
• W2598334911 countsByYear W25983349112018 @default.
• W2598334911 countsByYear W25983349112019 @default.
• W2598334911 countsByYear W25983349112020 @default.
• W2598334911 countsByYear W25983349112021 @default.
• W2598334911 countsByYear W25983349112022 @default.
• W2598334911 crossrefType "journal-article" @default.
• W2598334911 hasAuthorship W2598334911A5006467688 @default.
• W2598334911 hasAuthorship W2598334911A5007497847 @default.
• W2598334911 hasAuthorship W2598334911A5029942953 @default.
• W2598334911 hasAuthorship W2598334911A5050034362 @default.
• W2598334911 hasAuthorship W2598334911A5058921891 @default.
• W2598334911 hasAuthorship W2598334911A5072835730 @default.
• W2598334911 hasBestOaLocation W25983349111 @default.
• W2598334911 hasConcept C104317684 @default.
• W2598334911 hasConcept C121608353 @default.
• W2598334911 hasConcept C126322002 @default.
• W2598334911 hasConcept C149011108 @default.
• W2598334911 hasConcept C184235292 @default.
• W2598334911 hasConcept C185592680 @default.
• W2598334911 hasConcept C2776131300 @default.
• W2598334911 hasConcept C2778472372 @default.
• W2598334911 hasConcept C2778830669 @default.
• W2598334911 hasConcept C2994587330 @default.
• W2598334911 hasConcept C55493867 @default.
• W2598334911 hasConcept C57074206 @default.
• W2598334911 hasConcept C71924100 @default.
• W2598334911 hasConcept C86803240 @default.
• W2598334911 hasConcept C98274493 @default.
• W2598334911 hasConceptScore W2598334911C104317684 @default.
• W2598334911 hasConceptScore W2598334911C121608353 @default.
• W2598334911 hasConceptScore W2598334911C126322002 @default.
• W2598334911 hasConceptScore W2598334911C149011108 @default.
• W2598334911 hasConceptScore W2598334911C184235292 @default.
• W2598334911 hasConceptScore W2598334911C185592680 @default.
• W2598334911 hasConceptScore W2598334911C2776131300 @default.
• W2598334911 hasConceptScore W2598334911C2778472372 @default.
• W2598334911 hasConceptScore W2598334911C2778830669 @default.
• W2598334911 hasConceptScore W2598334911C2994587330 @default.
• W2598334911 hasConceptScore W2598334911C55493867 @default.
• W2598334911 hasConceptScore W2598334911C57074206 @default.
• W2598334911 hasConceptScore W2598334911C71924100 @default.
• W2598334911 hasConceptScore W2598334911C86803240 @default.
• W2598334911 hasConceptScore W2598334911C98274493 @default.
• W2598334911 hasIssue "6" @default.
• W2598334911 hasLocation W25983349111 @default.
• W2598334911 hasLocation W25983349112 @default.
• W2598334911 hasOpenAccess W2598334911 @default.
• W2598334911 hasPrimaryLocation W25983349111 @default.
• W2598334911 hasRelatedWork W1990093058 @default.
• W2598334911 hasRelatedWork W2058633833 @default.
• W2598334911 hasRelatedWork W2100105805 @default.

• next